Allergan Aesthetics Invites Consumers to Join the Faces of Natrelle® Campaign
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced a nationwide open casting call in search of the next Faces of Natrelle®, encouraging women who have experienced breast reconstruction and ...
Morningstar7d
Allergan Aesthetics Invites Consumers to Join the Faces of Natrelle® Campaign
Talk to your doctor about other complications. At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics ...
Mena FN6d
Allergan Aesthetics Invites Consumers To Join The Faces Of Natrelle® Campaign
(MENAFN- PR Newswire) "The Faces of Natrelle ® campaign is more than just celebrating physical beauty," said Carrie Strom, Senior Vice President, AbbVie and President, Global Allergan Aesthetics.
The Victoria Advocate7d
Allergan Aesthetics Invites Consumers to Join the Faces of Natrelle® Campaign
Breast implants are not considered lifetime devices. The longer people have them, the greater the chances are that they will develop complications, some of which will require more surgery. Breast ...
STAT23d
Final sale: my eight-year struggle to return recalled breast implants
In 2016, I became the owner of a dangerous product that has since been recalled. Considering its significant cost — an average of $4,875, not including “anesthesia, operating room facilities ...
Le Lézard7d
Allergan Aesthetics Invites Consumers to Join the Faces of Natrelle® Campaign
The sale and distribution of Natrelle ® Breast Implants is restricted ... the risks and benefits of breast implant surgery. About Allergan Aesthetics At Allergan Aesthetics, an AbbVie company ...
pharmaphorum4d
Allergan pulls breast implants after link to rare cancer
although the recall does raise the spectre of potential liability suits down the line for Allergan /AbbVie. The affected product range – sold under the Biocell banner – include Natrelle ...
Le Lézard7d
Spring Health Study Published in JAMA Network Open Demonstrates 1.9x ROI of Employer-Sponsored Behavioral Health Benefits
Health, the leading global mental health solution for employers and health plans, today unveiled data from a peer-reviewed study that validates the return on investment (ROI) of employer-sponsored ...
MM&M1d
The Escalator: Pfizer, Vertex Pharmaceuticals, Inizio and more
Pfizer announced Jeffrey Legos, PhD, MBA as its new chief oncology officer. Bluejay Therapeutics announced Mary Cromwell, PhD, has joined its leadership team as SVP and head of technical operations.